Loading insider details...
Latest Form 4 (Mar 11, 2024): Grant/Award of 415 HARP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 11, 2024 | Harpoon Therapeutics, Inc. (HARP) | Grant/Award | 415 | n/a |
| Aug 4, 2022 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 350,000 | n/a |
| Nov 11, 2021 | Calithera Biosciences, Inc. (CALA) | Purchase | 200,000 | $171.9K |
| Aug 26, 2021 | Neoleukin Therapeutics, Inc. (NLTX) | Purchase | 100,000 | $611.1K |
| Aug 5, 2021 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 400,000 | n/a |
| Jun 14, 2021 | Calithera Biosciences, Inc. (CALA) | Grant/Award | 20,000 | n/a |
| Jun 7, 2021 | Neoleukin Therapeutics, Inc. (NLTX) | Purchase | 40,000 | $379.3K |
| Aug 12, 2020 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 420,000 | n/a |
| Jun 11, 2020 | Calithera Biosciences, Inc. (CALA) | Grant/Award | 20,000 | n/a |